Found: 81
Select item for more details and to access through your institution.
The Future of Research in Multiple Sclerosis.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 8, p. 853, doi. 10.1001/jamaneurol.2015.0270
- By:
- Publication type:
- Article
A 29-year-old man with multiple sclerosis.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metrics.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, p. 1, doi. 10.1177/20552173211069852
- By:
- Publication type:
- Article
Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211004634
- By:
- Publication type:
- Article
Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 2, p. 1, doi. 10.1177/20552173211004634
- By:
- Publication type:
- Article
Long-Term Magnetization Transfer Ratio Evolution in Multiple Sclerosis White Matter Lesions.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of Disease-Modifying Therapies on Brain and Spinal Cord Atrophy in Multiple Sclerosis.
- Published in:
- Journal of Neuroimaging, 2004, v. 14, p. 54, doi. 10.1111/j.1552-6569.2004.tb00279.x
- By:
- Publication type:
- Article
Chemokine receptors as biomarkers in multiple sclerosis.
- Published in:
- Disease Markers, 2006, v. 22, n. 4, p. 227, doi. 10.1155/2006/694283
- By:
- Publication type:
- Article
Eight-year immunogenicity and safety of interferon beta-1a-Avonex® treatment in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2005, v. 11, n. 4, p. 409, doi. 10.1191/1352458505ms1209oa
- By:
- Publication type:
- Article
Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.
- Published in:
- Multiple Sclerosis (13524585), 2005, v. 11, n. 2, p. 140, doi. 10.1191/1352458505ms1142oa
- By:
- Publication type:
- Article
Factors that predict Health-Related Quality of Life in patients with relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2003, v. 9, n. 1, p. 1, doi. 10.1191/1352458503ms888oa
- By:
- Publication type:
- Article
Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis?
- Published in:
- Multiple Sclerosis (13524585), 2003, v. 9, n. 2, p. 210, doi. 10.1191/1352458503ms892rr
- By:
- Publication type:
- Article
Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon β-la.
- Published in:
- Multiple Sclerosis (13524585), 2000, v. 6, n. 6, p. 365, doi. 10.1177/135245850000600601
- By:
- Publication type:
- Article
Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25).
- Published in:
- Multiple Sclerosis (13524585), 2000, v. 6, n. 6, p. 382, doi. 10.1177/135245850000600604
- By:
- Publication type:
- Article
Expression of CCR2, CCR5, and CXCR3 by CD4+ T Cells is Stable During a 2-Year Longitudinal Study but Varies Widely Between Individuals.
- Published in:
- Journal of NeuroVirology, 2003, v. 9, n. 3, p. 291, doi. 10.1080/13550280390201001
- By:
- Publication type:
- Article
Natalizumab for the treatment of relapsing multiple sclerosis.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 2, p. 189
- By:
- Publication type:
- Article
Disease modification in multiple sclerosis: Issues with relevance to clinical trial designs in Alzheimer’s disease
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2006, v. 2, n. 3, p. 143, doi. 10.1016/j.jalz.2006.03.011
- By:
- Publication type:
- Article
Heterogeneous, Longitudinally Stable Molecular Signatures in Response to Interferon-β.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1182, n. 1, p. 58, doi. 10.1111/j.1749-6632.2009.05068.x
- By:
- Publication type:
- Article
Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 10, p. 1497, doi. 10.1177/1352458520972573
- By:
- Publication type:
- Article
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1691, doi. 10.1177/1352458519885613
- By:
- Publication type:
- Article
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1781, doi. 10.1177/1352458518808204
- By:
- Publication type:
- Article
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 11, p. 1469, doi. 10.1177/1352458517723718
- By:
- Publication type:
- Article
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 721, doi. 10.1177/1352458517690821
- By:
- Publication type:
- Article
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 711, doi. 10.1177/1352458517690824
- By:
- Publication type:
- Article
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 704, doi. 10.1177/1352458517690823
- By:
- Publication type:
- Article
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 734, doi. 10.1177/1352458517690822
- By:
- Publication type:
- Article
Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 4, p. 457, doi. 10.1177/1352458514544536
- By:
- Publication type:
- Article
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 1, p. 12, doi. 10.1177/1352458513503392
- By:
- Publication type:
- Article
Preventing brain atrophy should be the gold standard of effective therapy in MS (after the first year of treatment): Yes.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 8, p. 1003, doi. 10.1177/1352458513482385
- By:
- Publication type:
- Article
Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019262
- By:
- Publication type:
- Article
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
- Published in:
- Journal of Neurology, 2009, v. 256, n. 3, p. 405, doi. 10.1007/s00415-009-0093-1
- By:
- Publication type:
- Article
Web-Based Self-Management for Patients with Multiple Sclerosis: A Practical, Randomized Trial.
- Published in:
- Telemedicine & e-Health, 2011, v. 17, n. 1, p. 5, doi. 10.1089/tmj.2010.0133
- By:
- Publication type:
- Article
Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability.
- Published in:
- Neuroscientist, 1999, v. 5, n. 1, p. 48, doi. 10.1177/107385849900500107
- By:
- Publication type:
- Article
Health-Related Quality of Life in Multiple Sclerosis: Current Evidence, Measurement and Effects of Disease Severity and Treatment.
- Published in:
- CNS Drugs, 2008, v. 22, n. 10, p. 827, doi. 10.2165/00023210-200822100-00004
- By:
- Publication type:
- Article
The Future of Research in Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 8, p. 853, doi. 10.1001/jamaneurol.2015.0270
- By:
- Publication type:
- Article
The Clinical Meaning of Walking Speed as Measured by the Timed 25-Foot Walk in Patients With Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 11, p. 1386, doi. 10.1001/jamaneurol.2014.1895
- By:
- Publication type:
- Article
Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 3, p. 338, doi. 10.1001/2013.jamaneurol.211
- By:
- Publication type:
- Article
Development of a multiple sclerosis functional composite as a clinical trial outcome measure.
- Published in:
- Brain: A Journal of Neurology, 1999, v. 122, n. 5, p. 871, doi. 10.1093/brain/122.5.871
- By:
- Publication type:
- Article
Multiple Sclerosis, Bernie O'Brien.
- Published in:
- Neurorehabilitation & Neural Repair, 1988, v. 2, n. 3, p. 143, doi. 10.1177/154596838800200312
- By:
- Publication type:
- Article
Associations of sNfL with clinico‐radiological measures in a large MS population.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 1, p. 84, doi. 10.1002/acn3.51704
- By:
- Publication type:
- Article
Measuring treatment response to advance precision medicine for multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 11, p. 2166, doi. 10.1002/acn3.51471
- By:
- Publication type:
- Article
Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 5, p. 1096, doi. 10.1002/acn3.51354
- By:
- Publication type:
- Article
Development of a Highly Sensitive Neurofilament Light Chain Assay on an Automated Immunoassay Platform.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.935382
- By:
- Publication type:
- Article
Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.
- Published in:
- Annals of Neurology, 2013, v. 73, n. 1, p. 95, doi. 10.1002/ana.23758
- By:
- Publication type:
- Article
Diagnostic criteria in multiple sclerosis: Headed in the right direction but still a ways to go.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 2, p. 234, doi. 10.1002/ana.22388
- By:
- Publication type:
- Article
Reply.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 1, p. 216, doi. 10.1002/ana.22309
- By:
- Publication type:
- Article
Assessment of JC virus DNA in blood and urine from natalizumab-treated patients.
- Published in:
- Annals of Neurology, 2010, v. 68, n. 3, p. 304, doi. 10.1002/ana.22107
- By:
- Publication type:
- Article
Gray matter atrophy in multiple sclerosis: A longitudinal study.
- Published in:
- Annals of Neurology, 2008, v. 64, n. 3, p. 255, doi. 10.1002/ana.21436
- By:
- Publication type:
- Article
Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions.
- Published in:
- 2008
- By:
- Publication type:
- journal article